Abandoning the Proteinopathy Paradigm in Parkinson Disease

JAMA Neurol. 2023 Feb 1;80(2):123-124. doi: 10.1001/jamaneurol.2022.4193.
No abstract available

Plain language summary

This Viewpoint makes a case for changing the approach in Parkinson disease research efforts from one of proteinopathy (accrual of amyloids) to proteinopenia (depletion of normal proteins).

MeSH terms

  • Humans
  • Parkinson Disease*
  • Proteostasis Deficiencies*
  • TDP-43 Proteinopathies*